Don’t Miss This FREE Live Trading Summit

On May 8, a 25-year trading veteran reveals the “market maker” strategy that’s pinpointing gains as high as 197%, 317%, even 1,147% in 30 days or less.

Wed, May 8 at 10:00AM ET
 
 
 
 
Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026

Investors looking for discounted stocks to reap big gains by 2026 might be interested in these three top-notch picks.

3 Biotech Stocks With Skyrocketing Potential: April 2024

These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.

Why Is Amesite (AMST) Stock Up 74% Today?

Amesite stock is up on Wednesday with heavy trading of AMST shares following the launch of a beta for its AI nurse assistant app.

Why Is Evotec (EVO) Stock Down 33% Today?

Evotec stock is falling on Wednesday as EVO investors react to a lackluster 2024 revenue guidance in its 2023 earnings results.

3 Red-Hot Biotech Rockets Blasting Off in 2024

The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.

Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?

Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.

Undervalued Icons: 3 Household Names Trading at Steep Discounts

Three of Wall Street's undervalued stocks could provide a unique blend of stability and long-term growth potential.

Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?

Hepion Pharmaceuticals stock is falling on Monday as investors in HEPA learn of the company winding down a Phase 2b clinical trial.

Why Is Vaxxinity (VAXX) Stock Down 58% Today?

Vaxxinity stock is falling hard on Monday after the company announced plans to voluntarily delist shares of VAXX stock next month.

3 Biotech Stocks Set to Double by 2028

These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.

RWOD Stock: 7 Things to Know About the Anew Medical Merger

Redwoods Acquisition stock is up on Friday alongside RWOD shareholder approval for the company's SPAC merger with Anew Medical.

Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?

BioNexus Gene Lab stock is falling hard on Friday but that's only after shares of BGLC underwent a massive rally late on Thursday.

Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now

Investors should not ignore these highly rated stocks to buy now because they deserve their reputation as the market heats up.

The Dividend Goldmine: 3 Shining Stocks With Growing Payouts

Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns.

7 Stocks Under $15 Predicted to Boom in the Next 2 Years

Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.

Why Is Bio-Path (BPTH) Stock Up 89% Today?

Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.

Why Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today?

NRX Pharmaceuticals stock is down on Thursday after the company announced a public offering for NRXP shares after just avoiding delisting.

Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today?

Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares.